Clinical and economic aspects of chondroitin sulfate in osteoarthritis management: a brief review of recent evidence.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 294, doi. 10.30827/ars.v63i3.24587
- By:
- Publication type:
- Article
Works matching IS 00042927 AND DT 2022 AND VI 63 AND IP 3
Results: 8
1
2
Pictogramas farmacéuticos: ¿una oportunidad para la Alfabetización en Salud?
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 274, doi. 10.30827/ars.v63i3.23979
- By:
- Publication type:
- Article
3
Effect of an intervention New Medicine Service to improve adherence in the Spanish community pharmacies: a protocol of a pragmatic randomised trial.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 263, doi. 10.30827/ars.v63i3.24625
- By:
- Publication type:
- Article
4
La anfotericina B normalmente es subdosificada en el tratamiento de la leishmaniasis cutánea experimental.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 253, doi. 10.30827/ars.v63i3.23894
- By:
- Publication type:
- Article
5
Vigilancia de seguridad del inyectable en solución Heparina sódica 5000UI/mL a partir de notificaciones espontáneas.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 244, doi. 10.30827/ars.v63i3.23980
- By:
- Publication type:
- Article
6
Macrogol: Evaluación de la percepción de efectividad y calidad de vida en individuos con estreñimiento.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 234, doi. 10.30827/ars.v63i3.24409
- By:
- Publication type:
- Article
7
Un nuevo camino en la Atención Farmacéutica: la idoneidad de la Evaluación Clínica Objetiva Estructurada.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 222, doi. 10.30827/ars.v63i3.24104
- By:
- Publication type:
- Article
8
Development and evaluation of Deferasirox loaded nanoparticles for the treatment of Breast cancer: evaluation in-vitro and cell line study.
- Published in:
- Ars Pharmaceutica, 2022, v. 63, n. 3, p. 209, doi. 10.30827/ars.v63i3.22142
- By:
- Publication type:
- Article